These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15721422)

  • 1. Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment.
    Díaz-Montes TP; Alberg A; Zahurak ML; Trimble EL; Bristow RE
    Gynecol Oncol; 2005 Mar; 96(3):753-9. PubMed ID: 15721422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women.
    Kouri EM; He Y; Winer EP; Keating NL
    Breast Cancer Res Treat; 2010 Jun; 121(3):743-51. PubMed ID: 19949856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
    Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
    Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data.
    Gnerlich J; Dueker JM; Jeffe DB; Deshpande AD; Thompson S; Margenthaler JA
    Breast J; 2008; 14(6):538-42. PubMed ID: 19000055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival among U.S. women with invasive epithelial ovarian cancer.
    McGuire V; Jesser CA; Whittemore AS
    Gynecol Oncol; 2002 Mar; 84(3):399-403. PubMed ID: 11855877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population characteristics in cervical cancer trials: search for external validity.
    Yessaian A; Mendivil AA; Brewster WR
    Am J Obstet Gynecol; 2005 Feb; 192(2):407-13. PubMed ID: 15695979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.
    Ueda SM; Kapp DS; Cheung MK; Shin JY; Osann K; Husain A; Teng NN; Berek JS; Chan JK
    Am J Obstet Gynecol; 2008 Feb; 198(2):218.e1-6. PubMed ID: 18226630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
    Joslyn SA
    Breast J; 2006; 12(1):20-7. PubMed ID: 16409583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
    El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
    Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer incidence in the United States by area of residence, 1998 2001.
    Benard VB; Coughlin SS; Thompson T; Richardson LC
    Obstet Gynecol; 2007 Sep; 110(3):681-6. PubMed ID: 17766618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
    Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
    Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
    Al-Refaie WB; Tseng JF; Gay G; Patel-Parekh L; Mansfield PF; Pisters PW; Yao JC; Feig BW
    Cancer; 2008 Aug; 113(3):461-9. PubMed ID: 18553367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
    Chan JK; Kapp DS; Cheung MK; Shin JY; Stieglitz D; Husain A; Teng NN; Berek JS; Osann K; Guo H
    Am J Obstet Gynecol; 2008 Feb; 198(2):216.e1-5. PubMed ID: 18226629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.